C4 Therapeutics, Inc.
CCCC
Revenue
15.36M
▲3.36M▲27.95%
3 Months ChangeAssets
376.06M
▼-5.03M▼-1.32%
3 Months ChangeLiabilities
133.40M
▼-631.00k▼-0.4708%
3 Months ChangeFree Cash Flow
-18.12M
▲15.60M▲46.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044411
2024-10-31
Form 8-K
ID: 0001628280-24-044409
2024-10-15
Form 8-K
ID: 0001628280-24-042833
2024-10-11
Form 8-K
ID: 0001628280-24-042728
2024-09-03
Form 8-K
ID: 0001628280-24-039023
2024-08-01
Form 10-Q
ID: 0001628280-24-033882
2024-08-01
Form 8-K
ID: 0001628280-24-033874
2024-06-21
Form 8-K
ID: 0001628280-24-029301
2024-06-10
Form 8-K
ID: 0001628280-24-027399
2024-05-08
Form 10-Q
ID: 0001628280-24-021368